HE4 Tumor Marker

Minimum Order: 1

Packaging: N/A

Delivery: 15 Days

Human Epididymis Protein 4 (HE4 tumor marker) Is a Secreted Glycoprotein that Serous and Endometrioid Ovarian Carcinomas overexpress.

CA 125 is the most commonly used serum marker to monitor therapeutic response and detect disease recurrence in patients treated for epithelial ovarian cancer.

The National Comprehensive Cancer Network recommends CA 125 measurement before each treatment cycle and at each follow-up evaluation for women with elevated pretreatment concentrations. However, CA 125 is not elevated in all patients with epithelial ovarian cancer and is not specific to ovarian cancer. For this reason, physicians measure Human Epididymis Protein 4 (he4 tumour marker) in addition to CA 125.3 HE4 was first identified in the epithelium of the distal epididymis and originally predicted to be a protease inhibitor involved in sperm maturation.

HE4 marker overexpresses in 93 percent of serious, 100 percent of endometrioid epithelial ovarian cancers, and 50 percent of clear cell (not mucinous) ovarian carcinomas. HE4 secrete into the circulation resulting in elevated serum levels.

HE4 Tumour Marker Intro

Human epididymal protein 4 (HE4 Tumour Marker) is a novel ovarian cancer-specific tumor marker with higher specificity and sensitivity than cancer antigen 125 marker. HE4 is a secreted glycoprotein encoded by the WFDC2 gene with a molecular weight of about 25kD. It is mainly overexpressed in ovarian epithelial and endometrial cancer and has a specific positive rate in lung cancer and gastric cancer. Overexpression of HE4 can promote the proliferation, invasion, and metastasis of ovarian cancer cells. It consists of two core structures: a native N-terminal glycosylated protein of approximately 25KDa and two whey acidic protein core regions (WAP, consisting of 4 disulfide-bonded core regions and eight cysteine residues). The specificity and positive predictive value of HE4 detection alone were higher, and the combined detection of CA125 had higher sensitivity and significantly improved the negative predictive value and diagnostic accuracy. Human epididymal protein 4 (HE4) is a novel ovarian cancer-specific tumor marker with higher specificity and sensitivity than CA125. HE4 is a secreted glycoprotein encoded by the WFDC2 gene with a molecular weight of about 25kD. It is mainly overexpressed in ovarian epithelial and endometrial cancer and has a specific positive rate in lung cancer and gastric cancer. Overexpression of HE4 can promote the proliferation, invasion, and metastasis of ovarian cancer cells. It consists of two core structures: a native N-terminal glycosylated protein of approximately 25KDa and two whey acidic protein core regions (WAP, consisting of 4 disulfide-bonded core regions and eight cysteine residues). The specificity and positive predictive value of HE4 detection alone were higher, and the combined detection of CA125 had higher sensitivity and significantly improved the negative predictive value and diagnostic accuracy.

HE4 Tumor Marker Importance

Under normal physiological conditions, HE4 tumour marker has a deficient expression level in the human body. Still, it is highly expressed in ovarian cancer tissue and patient serum, and HE4 can be used for early diagnosis, identification, treatment monitoring, and prognosis evaluation of ovarian cancer. 88% of ovarian cancer patients will have elevated HE4 tumour marker. Compared with CA125, HE4 tumour marker is more sensitive and specific, especially in the initial asymptomatic stage of the disease. The diagnostic sensitivity of HE4 in the early stage of the disease was 82.7%, while that of CA125 was only 45.9%. The specificity of HE4 is as high as 99% compared to the specificity of CA125 of only 20%, which means that clinicians have more confidence in the HE4 test results. When a clinician diagnoses ovarian cancer solely based on a CA125 test, 8 out of 10 women may be misdiagnosed. HE4 and CA125 are complementary markers. The combined application of the two can increase the sensitivity to 92%, reduce false-negative results by 30%, and significantly increase the accuracy of an ovarian cancer diagnosis.

Sekbio is an immunodiagnostic raw material manufacturer. Our mission is to make diagnostics more accurate.

Country: China (Mainland)
Business Type:
Market:
Founded Year:
Address:B503, Building 1, Phase II, Yinxing Science and Technology Park, Guanlan, Shenzhen, China
Contact:sekbio .com

he4 tumor marker

*Your name:	Enter name here eg:Ralph zhang
*Your Email:	Enter email here
*To:	Shenzhen SEKBIO Co., Ltd
*Subject:
*Message:
	Enter between 20 to 3,000 characters. English only. Characters : 0 / 3000
*Enter the secure code shown below	Reload Image

		We do inquire for you , please wait ...

25-OH Vitamin D

Tumor Marker

Triiodothyronine (T3)

Thyroid Function

Squamous Cell Carcinoma (SCC)

cea test tumor marker

Types of Cardiac Marker Rapid Test Project Sample Format CK-MB Antigen Rapid Test Whole Blood / Serum / Plasma Strip / Device / Uncut Sheet Myoglobin Antibody Rapid Test Whole Blood / Serum / Plasma Strip / Device / Uncut Sheet Troponin 1 Antibody Rapid Test Whole Blood / Serum ...

Hanzghou Frenovo Biotech Co.,Ltd.

Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)

In the absence of vitamin K, liver cells cannot depend on vitamin K in the synthesis of standard clotting factors, only the synthesis of no function of blood coagulation abnormal prothrombin (DCP) -- pivka 2 tumor marker , is the protein induced by vitamin K deficiency or ...

Shenzhen SEKBIO Co., Ltd

Prostate-Specific Antigen (PSA Tumor Marker)

Prostate-specific antigen （PSA specific antigen）, also known as gamma-selenoprotein or kallikrein-3, is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the ...

Shenzhen SEKBIO Co., Ltd

Tumor Marker Rapid Test

What Are Tumor Markers? A tumor marker is anything present in or produced by cancer cells or other cells of the body in response to cancer or certain benign (noncancerous) conditions that provides information about cancer, such as how aggressive it is, what kind of treatment it ...

Hanzghou Frenovo Biotech Co.,Ltd.

CA50 Tumor Marker

CA50 is a kind of sialic acid ester and sialic acid glycoprotein, which generally does not exist in normal tissues. When cells become malignant, glycosylation enzyme is activated, resulting in changes of glycosylation structure on the cell surface and becoming A MARKER of CA50. ...

Shenzhen SEKBIO Co., Ltd

Tumor Marker

A ca tumour marker is a chemical substance that reflects the presence of a Tumor. It is present in malignant tumour cells, not in normal adult tissues, and substances abnormally produced by malignant tumour cells or by the host\'s response to tumour stimulation created it. ...

Shenzhen SEKBIO Co., Ltd

95 Tumor Markers

Fast results Easy visually interpretation Simple operation, no equipment required High accuracy The AFP Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of AFP in whole blood, serum or plasma to aid in the diagnosis of Hepatocellular Carcinoma or ...

Beijing Easy-Sweet Bio-medical Science and Technology Co., Ltd.

Tumor Marker Test

A tumor marker is anything present in or produced by cancer cells or other cells of the body in response to cancer or certain benign (noncancerous) conditions that provides information about cancer, such as how aggressive it is, what kind of treatment it may respond to, or ...

Hipro Biotechnology Co.,Ltd